Vector’s picks of recent pediatric healthcare, science and innovation news.
Encryption wouldn’t have stopped Anthem’s data breach (MIT Technology Review)
Hackers got their hands on the personal information and Social Security numbers of 80 million people when they broke into the network of health insurer Anthem health. But encryption alone wouldn’t have been enough to keep those data safe.
Could a wireless pacemaker let hackers take control of your heart? (Science)
Medical devices like pacemakers, insulin pumps and defibrillators are getting ever smaller and more wirelessly connected. But are those connections secure enough?
Medicare getting stricter on covering high-priced therapies (MedPageToday)
The prices of blockbuster drugs, treatments and devices are going up up up, but a new report suggests that Medicare is pushing back. In fact, Medicare was 20 times less likely to approve a costly drug or device in 2012 than in 1999.
How much does the measles really cost taxpayers? (MedCity News)
Vaccination is cheap compared to the economic costs of treating measles and containing an epidemic.
“FDA has repeatedly hidden evidence of scientific fraud,” says author of new study (Retraction Watch)
Over the years, according to a report in JAMA Internal Medicine, the FDA’s reaction upon discovering misconduct in clinical trials—such as falsified data and “failure to protect the safety of patients”— has been, essentially, nothing.
Big pharma faces some big patent losses, but pipelines are improving (Wall Street Journal’s Pharmalot)
Pharmaceutical companies are trying to shift investors’ attention from drugs going off patent to new drugs in their pipeline. A Moody’s analysis suggests some of those pipelines are more robust than others.